Evidence map›Paper›PMID 32124171›Full record

ArticleMolecular biology reports2020

The effect of ellagic acid on caspase-3/bcl-2/Nrf-2/NF-kB/TNF-α /COX-2 gene expression product apoptosis pathway: a new approach for muscle damage therapy.

Abdullah Aslan, Seda Beyaz, Ozlem Gok, Orhan Erman

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Renal protection by ellagic acid in a rat model of glycerol-induced acute kidney injury.Veterinary research forum : an international quarterly journal · 2024
    Article
  9. Article
  10. Article
  11. Fullerene CCardiovascular toxicology · 2023
    Article
  12. Review
  13. Article
  14. Review
  15. Sphingosine 1-Phosphate-Upregulated COX-2/PGEOxidative medicine and cellular longevity · 2022
    Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Abdullah AslanDepartment of Biology, Molecular Biology and Genetics Program, Faculty of Science, Firat University, Elazig, Turkey. aaslan@firat.edu.tr.
Seda BeyazDepartment of Biology, Faculty of Science, Firat University, Elazig, Turkey.
Ozlem GokDepartment of Biology, Faculty of Science, Firat University, Elazig, Turkey.
Orhan ErmanDepartment of Biology, Faculty of Science, Firat University, Elazig, Turkey.
Fırat University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The goal of this study was to determine the protective role of ellagic acid (EA) against CCl

Indexed as

AnimalsAntioxidantsApoptosisCaspase 3CatalaseCyclooxygenase 2Ellagic AcidGene ExpressionGlutathioneGlutathione PeroxidaseLipid PeroxidationMaleMuscle, SkeletalNF-E2-Related Factor 2Oxidative StressProto-Oncogene Proteins c-bcl-2AntioxidantsCaspase 3CatalaseCyclooxygenase 2Ellagic AcidGlutathioneGlutathione PeroxidaseNF-E2-Related Factor 2Proto-Oncogene Proteins c-bcl-2Tumor Necrosis Factor-alphaBcl-2COX-2Ellagic acidMuscle damageNF-kBNrf-2TNF-α

Identifiers

PMID32124171
OpenAlexW3009762687

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.